Suchergebnisse - "Capdevila, Jaume"

PubPharm (66)

1

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Romesser, P. | Capdevila, J. | Garcia-Carbonero, R. | +10

2

Total neoadjuvant therapy with or without aflibercept in rectal cancer : 3-year results of GEMCAD-1402

enthalten in: Journal of the National Cancer Institute | 2023

von Pesántez, D. | Ten Hoorn, S. | Machado, I. | +19

CommentIn: J Natl Cancer Inst. 2023 Oct 18;:. - PMID 37851864

3

A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials

enthalten in: Med (New York, N.Y.) | 2023

von Hernando-Calvo, A. | Vila-Casadesús, M. | Bareche, Y. | +35

4

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery : A 5-Year Follow-up of the RAPIDO Trial

enthalten in: Annals of surgery | 2023

von Dijkstra, E. | Nilsson, P. | Hospers, G. | +15

CommentIn: Ann Surg Open. 2023 Jun 02;4(2):e288. - PMID 37601460

5

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer : a multidisciplinary perspective for daily practice

enthalten in: European thyroid journal | 2023

von Capdevila, J. | Deandreis, D. | Durante, C. | +9

6

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study

enthalten in: Cancer | 2023

von Oh, D. | Algazi, A. | Capdevila, J. | +14

7

Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors : Targeting Genetically Driven Tumor Hypoxia

enthalten in: Endocrine reviews | 2023

von Toledo, R. | Jimenez, C. | Armaiz-Pena, G. | +3

8

Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer : Updated results from the phase 3 COSMIC-311 trial

enthalten in: Cancer | 2022

von Brose, M. | Robinson, B. | Sherman, S. | +11

ErratumIn: Cancer. 2023 Jan 13;:. - PMID 36637398

9

Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies

enthalten in: Cancer | 2022

von Hollebecque, A. | Salvagni, S. | Plummer, R. | +17

10

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2022

von Dijkstra, E. | Hospers, G. | Kranenbarg, E. | +15

1
2
3
4
5
6
7
Nächster »
[7]